The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Natpar



Shire Pharmaceuticals Ireland Limited EU/1/15/1078/003

Main Information

Trade NameNatpar
Active SubstancesParathyroid hormone (rdna)
Dosage FormPowder and solvent for solution for injection
Licence HolderShire Pharmaceuticals Ireland Limited
Licence NumberEU/1/15/1078/003

Group Information

ATC CodeH05AA Parathyroid hormones and analogues
H05AA03 parathyroid hormone

Status

Authorised/WithdrawnAuthorised
Licence Issued24/04/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back